Cargando…
Autophagy-Dependent Survival of Mutant B-Raf Melanoma Cells Selected for Resistance to Apoptosis Induced by Inhibitors against Oncogenic B-Raf
Most patients with mutant B-Raf melanomas respond to inhibitors of oncogenic B-Raf but resistance eventually emerges. To better understand the mechanisms that determine the long-term responses of mutant B-Raf melanoma cells to B-Raf inhibitor, we used chronic selection to establish B-Raf (V600E) mel...
Autores principales: | Ahn, Jun-Ho, Lee, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762312/ https://www.ncbi.nlm.nih.gov/pubmed/24009868 http://dx.doi.org/10.4062/biomolther.2013.012 |
Ejemplares similares
-
The genesis of Zelboraf: Targeting mutant B-Raf in melanoma
por: Davis, Matthew J., et al.
Publicado: (2012) -
Mutant B-RAF Regulates a Rac-dependent Cadherin Switch in Melanoma
por: Elizabeth, Monaghan-Benson, et al.
Publicado: (2012) -
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015) -
A new B-Raf inhibitor combo for advanced melanoma
por: Barysch, Marjam-Jeanette, et al.
Publicado: (2018) -
Melanoma whole exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance
por: Shi, Hubing, et al.
Publicado: (2012)